Search clinical trials for: pemetrexed and cisplatin
Total 271319 results
-
CanBas Co. Ltd.CompletedSolid Tumors | Malignant Pleural MesotheliomaUnited States
-
CanBas Co. Ltd.CompletedMetastatic Non-squamous Non Small Cell Lung CancerUnited States
-
Guangzhou Medical UniversityUnknownNon Small Cell Lung CancerChina
-
BayerTerminated
-
BeiGeneCompletedNon-Small Cell Lung CancerChina
-
Sun Yat-sen UniversityRecruitingCarcinoma，Non-Small-Cell LungChina
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerCanada
-
Yonsei UniversityActive, not recruitingSarcomaKorea, Republic of
-
Eli Lilly and CompanyCompletedGastrointestinal NeoplasmsKorea, Republic of
-
Shanghai Chest HospitalCompletedLung Adenocarcinoma | EGFR Activating Mutation
-
PfizerCompletedNSCLC (Non-small Cell Lung Cancer)Hong Kong, China, Taiwan, Malaysia, Thailand
-
Yonsei UniversityRecruiting
-
Eli Lilly and CompanyCompletedMalignant Pleural MesotheliomaJapan
-
University of KansasMerck Sharp & Dohme LLCCompletedNon Small Cell Lung CancerUnited States
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Eli Lilly and CompanyTerminated
-
Eli Lilly and CompanyCompletedPleural NeoplasmsUnited States
-
Sun Yat-sen UniversityUnknownBevacizumab | Brain Metastases | Non Squamous Non-small Cell Lung CancerChina
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Not yet recruitingAdvanced or Metastatic Non-squamous Non-small-cell Lung Cancer
-
Cancer Institute and Hospital, Chinese Academy...CompletedLocally Advanced Malignant NeoplasmChina
-
Eli Lilly and CompanyCompletedNeoplasm, GastricTaiwan, Argentina, Mexico, Korea, Republic of
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical CancerUnited States
-
Eli Lilly and CompanyTerminatedSmall Cell Lung Cancer | SCLC | Carcinoma, Small CellNetherlands, Belgium
-
Shantou University Medical CollegeUnknownPleural Effusion, MalignantChina
-
Fudan UniversityUnknownLocal Advanced Non-Small Cell Lung CancerChina
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedGastric CancerRussian Federation
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellDenmark, United Kingdom
-
Intergroupe Francophone de Cancerologie ThoraciqueUniversity Hospital, Caen; Groupe Français de Pneumo-CancérologieCompleted
-
University of Southern CaliforniaSponsor Name PendingWithdrawn
-
Sichuan UniversityChia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedNon-squamous Non-small-cell Lung Cancer | AnlotinibChina
-
Universität Duisburg-EssenEli Lilly and CompanyUnknown
-
Li Zhang, MDRecruitingCarcinoma, Non-Small-Cell LungChina
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Pleural MesotheliomaBelgium, Netherlands
-
University of ArizonaNational Cancer Institute (NCI)CompletedEsophageal CancerUnited States
-
University Hospital, BrestCompleted
-
UNICANCERCompletedMetastatic Cancer | Solid TumorsFrance
-
Memorial Sloan Kettering Cancer CenterWithdrawnMalignant Pleural MesotheliomaUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingNon-squamous Non-small-cell Lung CancerChina
-
European Organisation for Research and Treatment...Terminated
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingMesothelioma, Malignant | Mesothelioma, Malignant Pleural | Mesothelioma Malignant AdvancedChina
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Completed
-
AstraZenecaParexelActive, not recruitingNon-small Cell Lung CancerItaly, Spain, United States, China, Germany, Israel
-
AstraZenecaActive, not recruitingNon Small Cell Lung Cancer NSCLCPoland, United States, Taiwan, Thailand, Vietnam, Korea, Republic of, United Kingdom, Brazil, Hungary, Japan, Mexico, Peru, Russian Federation, China, Germany, South Africa, Ukraine, Bulgaria, Hong Kong
-
University Hospital, AntwerpEli Lilly and Company; Universiteit AntwerpenCompleted
-
Innate PharmaRecruitingNon Small Cell Lung CancerFrance, United States, Greece, Hungary, Poland
-
Spanish Lung Cancer GroupTerminatedCarcinoma, Non Small Cell LungSpain
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.UnknownApatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLCLung Cancer | Non Small Cell Lung Cancer | Apatinib | Combination ChemotherapyChina
-
Roswell Park Cancer InstituteCompleted
-
Duke UniversityEli Lilly and CompanyTerminatedCarcinoma, Non-Small-Cell LungUnited States